June 2025 Newsletter
Dear Friends and Colleagues,
As the summer unfolds, we’re taking a moment to reflect with gratitude and excitement on the progress we’ve made, both personally and professionally. The movement for psychedelics and cannabis law reform continues to gain momentum, and we’re honored to be part of it alongside so many inspiring clients, collaborators, and advocates.
We’re delighted to share several exciting updates from the Feldman Legal Advisors team:
1. A Joyous Occasion: David Feldman's Wedding in Formentera
We’re thrilled to share that our founding partner, David Feldman, recently tied the knot in a beautiful ceremony on the idyllic island of Formentera, Spain. It was a celebration full of love, laughter, and sea breezes. Congratulations to David and his partner, Siki, on this wonderful new beginning!
2. Chambers and Partners 2025 Rankings
We are incredibly proud to share that Feldman Legal Advisors PLLC, along with our attorneys Courtney Barnes and David Feldman, have once again been recognized in the 2025 Chambers and Partners rankings — a gold standard in the legal profession:
Feldman Legal Advisors PLLC: Band 1 — Psychedelics Law
(Ranked Band 1 for the second year in a row, since the launch of this category)Courtney Barnes: Band 1 — Psychedelics Attorney
(Ranked Band 1 for the second year in a row, since the launch of this category)David Feldman: Band 3 — Cannabis Attorney
(Honored for the seventh consecutive year)
Chambers and Partners is internationally recognized for its meticulous research and peer-driven evaluations. These distinctions affirm not only our legal acumen but our long-standing, heartfelt commitment to the transformative work taking place in the psychedelics and cannabis spaces.
3. Courtney Barnes Speaking at MAPS Psychedelic Science
Heading to MAPS’ Psychedelic Science 2025 Conference in Denver this week? Don’t miss Courtney Barnes as she takes the stage for a panel on future policy innovation:
📍 Panel: What Could the Next Iteration of a Psychedelic State Policy Look Like?
📅 Date: Thursday, June 19, 2025
🕰 Time: 12:20 PM MT
📌 Location: POLICY Track – Mile High Ballroom 2A
Visit psychedelicscience.org to register and plan your visit.
Interested in connecting with Courtney while you’re in town? Schedule a meeting with her here.
4. Major Policy Win: Texas Passes Ibogaine Research Bill
In a historic move, Texas has passed Senate Bill 2308, signed by Governor Greg Abbott, creating a framework to support ibogaine drug development clinical trials aimed at treating opioid use disorder, co-occurring substance use disorders, and other qualifying conditions.
The law enables the formation of a state-recognized consortium—comprised of a drug developer, a hospital, and an institution of higher education—to seek state funding and FDA approval for ibogaine-based therapies. The lead institution will administer the program and submit detailed trial proposals to the state, including plans for trial design, safety, access, and long-term care. The legislation ensures that Texas will hold a minimum 20% equity stake in any resulting intellectual property. A portion of that revenue—25%—is dedicated to supporting veterans' programs.
This law marks a significant advancement in psychedelic policy and biomedical innovation, positioning Texas at the forefront of state-backed psychedelic research.
Thank you for being part of our community.
Click the button below to schedule a complimentary
20-minute consultation with our team